AU4554500A - Substituted pyrazole derivative - Google Patents
Substituted pyrazole derivativeInfo
- Publication number
- AU4554500A AU4554500A AU45545/00A AU4554500A AU4554500A AU 4554500 A AU4554500 A AU 4554500A AU 45545/00 A AU45545/00 A AU 45545/00A AU 4554500 A AU4554500 A AU 4554500A AU 4554500 A AU4554500 A AU 4554500A
- Authority
- AU
- Australia
- Prior art keywords
- pyrazole derivative
- substituted pyrazole
- substituted
- derivative
- pyrazole
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19920352 | 1999-05-04 | ||
DE19920352A DE19920352A1 (en) | 1999-05-04 | 1999-05-04 | Substituted pyrazole derivative |
PCT/EP2000/003620 WO2000066582A1 (en) | 1999-05-04 | 2000-04-20 | Substituted pyrazole derivative |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4554500A true AU4554500A (en) | 2000-11-17 |
Family
ID=7906844
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU45545/00A Withdrawn AU4554500A (en) | 1999-05-04 | 2000-04-20 | Substituted pyrazole derivative |
Country Status (6)
Country | Link |
---|---|
AU (1) | AU4554500A (en) |
DE (1) | DE19920352A1 (en) |
GT (1) | GT200000062A (en) |
PE (1) | PE20010111A1 (en) |
UY (1) | UY26133A1 (en) |
WO (1) | WO2000066582A1 (en) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10021069A1 (en) * | 2000-04-28 | 2001-10-31 | Bayer Ag | Substituted pyrazole derivative |
AR031176A1 (en) | 2000-11-22 | 2003-09-10 | Bayer Ag | NEW DERIVATIVES OF PIRAZOLPIRIDINA SUBSTITUTED WITH PIRIDINE |
DE10122894A1 (en) * | 2001-05-11 | 2002-11-14 | Bayer Ag | New pyrazolo(3,4-b)pyridin-3-yl)-5-pyrimidinyl sulfonates, are soluble guanyl cyclase stimulants useful e.g. for treating cardiovascular, thromboembolic or central nervous system diseases |
ITMI20011308A1 (en) * | 2001-06-21 | 2002-12-21 | Nicox Sa | DRUGS FOR CHRONIC PAIN |
DE10132416A1 (en) * | 2001-07-04 | 2003-01-16 | Bayer Ag | New morpholine-bridged pyrazolopyridine derivatives |
DE10217799A1 (en) * | 2002-04-22 | 2003-11-06 | Bayer Ag | stents |
DE10242941A1 (en) * | 2002-09-16 | 2004-03-18 | Bayer Ag | New 2-(pyrazolo-(3,4-b)-pyridinyl)-5-pyridinyl-4-pyrimidinylamine derivative, is a soluble guanylate cyclase stimulant useful e.g. for treating cardiovascular diseases, hypertension or ischemia |
DE102007028319A1 (en) | 2007-06-20 | 2008-12-24 | Bayer Healthcare Ag | Substituted oxazolidinones and their use |
DE102007028320A1 (en) | 2007-06-20 | 2008-12-24 | Bayer Healthcare Ag | Substituted oxazolidinones and their use |
DE102007028407A1 (en) | 2007-06-20 | 2008-12-24 | Bayer Healthcare Ag | Substituted oxazolidinones and their use |
DE102007028406A1 (en) | 2007-06-20 | 2008-12-24 | Bayer Healthcare Ag | Substituted oxazolidinones and their use |
EP2138178A1 (en) | 2008-06-28 | 2009-12-30 | Bayer Schering Pharma Aktiengesellschaft | Oxazolidninones for the treatment fo chronic obstructive pulmonary disease (COPD) and/or asthma |
CA2856706C (en) | 2011-11-25 | 2020-06-16 | Bayer Pharma Aktiengesellschaft | Method for producing substituted 5-fluoro-1h-pyrazolopyridines |
KR102060376B1 (en) | 2012-05-10 | 2019-12-30 | 바이엘 파마 악티엔게젤샤프트 | Antibodies capable of binding to the coagulation factor xi and/or its activated form factor xia and uses thereof |
CN108463224A (en) | 2015-12-14 | 2018-08-28 | 铁木医药有限公司 | SGC stimulants are used for the application of gastrointestinal dysfunction treatment |
US20190381039A1 (en) | 2016-12-13 | 2019-12-19 | Cyclerion Therapeutics, Inc. | USE OF sGC STIMULATORS FOR THE TREATMENT OF ESOPHAGEAL MOTILITY DISORDERS |
US11242335B2 (en) | 2017-04-11 | 2022-02-08 | Sunshine Lake Pharma Co., Ltd. | Fluorine-substituted indazole compounds and uses thereof |
AU2019301683A1 (en) | 2018-07-11 | 2021-02-11 | Tisento Therapeutics Inc. | Use of sGC stimulators for the treatment of mitochonrial disorders |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19649460A1 (en) * | 1996-11-26 | 1998-05-28 | Bayer Ag | New substituted pyrazole derivatives |
DE19834047A1 (en) * | 1998-07-29 | 2000-02-03 | Bayer Ag | Substituted pyrazole derivatives |
-
1999
- 1999-05-04 DE DE19920352A patent/DE19920352A1/en not_active Withdrawn
-
2000
- 2000-04-20 AU AU45545/00A patent/AU4554500A/en not_active Withdrawn
- 2000-04-20 WO PCT/EP2000/003620 patent/WO2000066582A1/en not_active Application Discontinuation
- 2000-04-28 UY UY26133A patent/UY26133A1/en not_active Application Discontinuation
- 2000-05-03 PE PE2000000410A patent/PE20010111A1/en not_active Application Discontinuation
- 2000-05-04 GT GT200000062A patent/GT200000062A/en unknown
Also Published As
Publication number | Publication date |
---|---|
DE19920352A1 (en) | 2000-11-09 |
GT200000062A (en) | 2001-10-26 |
UY26133A1 (en) | 2000-12-29 |
WO2000066582A1 (en) | 2000-11-09 |
PE20010111A1 (en) | 2001-04-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5283999A (en) | Substituted pyrazole derivatives | |
AU2001267766A1 (en) | Pyrazole derivatives | |
AU6314900A (en) | Biarylurea derivatives | |
AU6714700A (en) | Cyclopropylindole derivatives | |
AU2001256769A1 (en) | Triazole derivatives | |
AU2001256305A1 (en) | Substituted pyrazole derivative | |
AU9459398A (en) | Pyrazole derivatives | |
AU7553198A (en) | Pyrazole derivatives | |
AU4554500A (en) | Substituted pyrazole derivative | |
AU2001229915A1 (en) | Pyrazole compounds | |
AU2623399A (en) | 3-hydroxy-4-aryl-5-pyrazoline derivatives as herbicides | |
AU2000223275A1 (en) | Novel triazole derivatives | |
AU5429000A (en) | Novel bicyclonucleoside derivatives | |
AU3429700A (en) | Substituted benzoylpyrazoles as herbicides | |
AU7319800A (en) | 4-oxybenzopyran derivative | |
AU2002213978A1 (en) | Substituted C-cyclohexylmethylamine derivatives | |
AU7952800A (en) | 2-alkoxybenzene derivatives | |
AU3670000A (en) | Novel thiazolobenzimidazole derivatives | |
AU5256301A (en) | Froindazole derivative | |
AU7453900A (en) | 4-oxybenzopyran derivative | |
AU2001289937A1 (en) | Substituted 1-aminobutan-3-ol derivatives | |
AU5887400A (en) | Derivative compounds | |
AU5577198A (en) | Pyrazole derivatives | |
AU3670900A (en) | Substituted fused imidazole derivatives | |
AU6262300A (en) | Indolinylamide derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK13 | Application withdrawn section 141(2)/reg 8.3(2) - pct appl. non-entering nat. phase, withdrawn by applicant |